Category: Market News

Feb 12
Gilead says in-vitro study shows its COVID-19 drug Veklury is active against omicron

Shares of Gilead Sciences Inc. GILD, +0.45% gained 0.6% in premarket trading on Friday after the company said Veklury, its COVID-19 drug, demonstrated in-vitro activity against omicron and 9 other variants. The research, which was announced in a news release on Friday morning, was published Thursday as a preprint. Gilead said the study has also […]

Feb 12
Twitter announces agreements with Morgan Stanley, Wells Fargo for $2 billion in accelerated share repurchases

Twitter Inc. TWTR, -3.34% said Friday morning that it has entered into agreements with Morgan Stanley & Co. MS, -2.79% and Wells Fargo Bank WFC, -1.25% to conduct $2 billion in accelerated share repurchases. The company previously announced a day earlier that it would launch a $2 billion accelerated repurchase program as part of a […]

Feb 12
SVB Leerink analyst doesn't expect cancer drug developed by Innovent and Lilly to be approved

Investors should expect to see fewer Food and Drug Administration approvals of copycat PD-L1 therapies after an advisory committee recommended against approving an experimental cancer drug, according to SVB Leerink analysts. The drug in question, sintilimab, is being developed by Innovent Biologics Inc. 1801, -7.47%, a Chinese drug maker, and Eli Lilly & Co. LLY, […]

Feb 12
Denny's offering free weddings at its Las Vegas chapel on Valentine's Day

Tonya Garcia is a MarketWatch reporter covering retail and consumer-oriented companies. You can follow her on Twitter @tgarcianyc. She is based in New York. Tonya joined MarketWatch from Moguldom Media, where she was business editor for MadameNoire, a website targeting African-American women with a range of content from personal finance to economics, politics, education and […]

Feb 12
Pfizer, BioNTech to delay seeking authorization of their COVID-19 shot in young children

Pfizer Inc. PFE, +0.36% and BioNTech SE BNTX, +2.04% said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clinical data evaluating three doses to seek emergency authorization in the […]

Feb 12
DoubleLine Capital's Gundlach sees Fed raising rates by more than the market expects

Bond king Jeffrey Gundlach, chief executive of DoubleLine Capital, said the Federal Reserve is “obviously” behind the curve on raising interest rates to combat higher inflation and that he expects the central bank to hike by more than markets expect. “How many months has it been that CPI has printed above expectations?” he said in […]

Feb 12
Russian invasion of Ukraine could begin 'any day now,' White House's Sullivan says

A Russian invasion of Ukraine could begin “any day now,” White House national-security adviser Jake Sullivan said Friday, telling reporters that Moscow is in position to mount a “major military action.” Sullivan said the U.S. isn’t saying Putin has made a final decision but still urged Americans in Ukraine to leave the country within 48 […]

Feb 12
Stocks extend slump as Ukraine fears rise; yields edge lower, gold and oil extend gains

U.S. stocks extended losses Friday afternoon, while Treasury yields pulled back and gold and oil prices rose as White House National Security Advisor Jake Sullivan warned that Russia was in position to mount an invasion of Ukraine “any day now.” He said the U.S. wasn’t saying that Russian President Vladimir Putin had made a final […]

Feb 12
Dow ends down 500 points as U.S. says Russia invasion of Ukraine could happen 'any day now'

Stocks ended sharply lower Friday after White House National Security Adviser Jake Sullivan warned that a Russian invasion of Ukraine could happen “any day now.” The Dow Jones Industrial Average DJIA, -1.43% fell 504 points, or 1.4%, to close near 34,737, according to preliminary figures, while the S&P 500 SPX, -1.90% dropped around 86 points, […]

Feb 11
Lilly's COVID-19 treatment gets FDA's emergency-use approval

Eli Lilly & Co. LLY, -1.63% said late Friday that the U.S. Food and Drug Administration has issued an emergency-use authorization for bebtelovimab, the pharma company’s antibody treatment for COVID-19. Bebtelovimab now can be used for the treatment of mild-to-moderate COVID-19 in adults as well as children older than 12 years of age and over […]